|
|
 |
SESAME OIL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM STARCH GLYCOLATE TYPE A CORN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SEGLUROMET Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM BICARBONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|